Duane, C., Glavey, S., Quinn, J. and Murphy, P. (2025) “Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on ‘Targeted anti-cancer agents and risk of venous thromboembolism’”, Haematologica. Pavia, Italy, 110(10), pp. 2552-2553. doi: 10.3324/haematol.2025.287442.